Salesforce heads into July with a fresh upgrade, a stabilising short book, and options traders turning more bullish — a meaningful shift from the defensive posture that defined most of June.
The standout this week is analyst movement. Guggenheim initiated coverage with a Buy and a $228 target on July 1, the most recent action in what has been a split Street. That upgrade matters because it arrives after a brutal month: the stock is down 18% over 30 days to $156.66, and most post-earnings revisions on May 28 were cuts. The bulls — 34 Buy ratings versus 9 Holds — point to the Agentforce monetisation story and the $3.6 billion Fin acquisition as near-term catalysts, arguing Salesforce is pricing AI value against labour outcomes rather than traditional software seats. The bears counter that macro headwinds, weakness in Marketing and Tableau, and a high implied takeout multiple on Fin leave the second-half revenue ramp unproven. The consensus mean target of $246 implies roughly 57% upside from current levels, though that gap largely reflects how far the stock has fallen rather than fresh target upgrades. One notable outlier: Needham's $400 target from June 16 looks disconnected from where the stock is trading and should be treated with caution.
Short positioning is broadly consistent with the picture described in last week's note, with some further unwinding. Short interest ticked up about 10% on the week to 38.9 million shares, or 4.1% of the free float — but that weekly move follows a month in which shorts fell by 38%. The rebuild from the mid-June lows is modest, and at 4% of float this remains background-level positioning for a stock of this size. Borrow costs rose 20% on the week to 0.52%, the highest level in about a month, but still firmly in "low" territory. More importantly, availability has loosened further to 1,429% of outstanding short interest — more than fourteen shares available for every one borrowed — so there is no sign of squeeze pressure. The borrow market is relaxed even as cost edges higher.
Options traders are leaning more constructively than they have in weeks. The put/call ratio has fallen to 0.67, nearly 1.7 standard deviations below its 20-day average of 0.71 — close to the lowest defensive positioning seen in the past year and well off the 0.88 peak hit in late May. That shift mirrors the short covering: hedging demand has eased sharply since the earnings-driven sell-off. The ORTEX short score has also drifted lower, from 45.5 on June 17 to 39.1 now, consistent with shorts continuing to step back rather than rebuild aggressively. Peer moves this week reinforce the sector backdrop — WDAY rose 6.3% and HUBS 5.3%, with GWRE the standout at 12.2%, while CRM's 2.1% gain kept pace with the softer end of the group.
The institutional picture offers some context. BlackRock added 1.25 million shares to reach 9.7% of the company as of end-May, and Capital Research added 445,000 shares. T. Rowe Price moved the other way, trimming 2.9 million shares. Insider activity on June 22 was routine — awards and small programmatic sells by co-presidents and the CTO at around $150, all with significance scores of 1. Nothing there changes the story.
The next earnings print is scheduled for August 26. After the May release produced a 7.7% one-day gain followed by a 6.3% five-day move, the question heading into that date is whether Agentforce adoption metrics and second-half guidance can validate the Street's recovery thesis — or whether the Fin acquisition costs and segment weaknesses keep the discount intact.
See the live data behind this article on ORTEX.
Open CRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
